Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Post-Mkt 12-11 18:46:33 EST

23.01

-0.35

-1.50%

盘后23.08

+0.07+0.30%

18:46 EST

High23.55	Low22.97	Vol1.60M
Open23.45	D1 Closing23.36	Amplitude2.47%
Mkt Cap4.25B	Tradable Cap1.87B	Total Shares184.69M
T/O36.94M	T/O Rate1.96%	Tradable Shares81.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":23.01,"timestamp":1765486800000,"preClose":23.36,"halted":0,"volume":1596542,"hourTrading":{"tag":"盘后","latestPrice":23.08,"preClose":23.01,"latestTime":"18:46 EST","volume":32443,"amount":746593.401995,"timestamp":1765496781052},"delay":0,"floatShares":81382003,"shares":184689564,"eps":-1.30264,"marketStatus":"Post-Mkt","change":-0.35,"latestTime":"12-11 18:46:33 EST","open":23.45,"high":23.548,"low":22.97,"amount":36940180.513498,"amplitude":0.024743,"askPrice":23.08,"askSize":18,"bidPrice":23.07,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-1.30264,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":23.36,"preHourTrading":{"tag":"盘前","latestPrice":23.62,"preClose":23.36,"latestTime":"09:28 EST","volume":1478,"amount":35059.25372,"timestamp":1765463280077},"postHourTrading":{"tag":"盘后","latestPrice":23.08,"preClose":23.01,"latestTime":"18:46 EST","volume":32443,"amount":746593.401995,"timestamp":1765496781052},"volumeRatio":0.375563,"impliedVol":0.5236,"impliedVolPercentile":0.312},"requestUrl":"/m/hq/s/LEGN/wiki","defaultTab":"wiki","newsList":[{"id":"2590953199","title":"Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2590953199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590953199?lang=en_us&edition=fundamental","pubTime":"2025-12-11 01:03","pubTimestamp":1765386224,"startTime":"0","endTime":"0","summary":"Legend Biotech's  share price weakness after the release of data from a phase 3 trial of a rival treatment for relapsed or refractory multiple myeloma is \"overdone\" as Legend's Carvykti can still be the preferred option, RBC Capital Markets said in a note emailed Wednesday.Johnson & Johnson's  teclistamab plus daratumumab therapy showed \"promising\" efficacy, the investment firm said.But Legend's Carvykti is still potentially the \"highest efficacy option, with one-and-done convenience, continued growth and penetration into early lines and the community setting,\" according to the note.The investment firm said it would be a buyer on Legend's weakness, and it expects near-term profitability for the company and further growth next year.RBC has an outperform rating on Legend stock and $74 price target.Price: 23.47, Change: -0.41, Percent Change: -1.73","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0345770993.USD","IE00BN8TJ469.HKD","IE00BKVL7J92.USD","LU2602419157.SGD","BK4505","LU2112291526.USD","LU1914381329.SGD","BK4559","IE00B42XCP33.USD","IE00BLSP4452.SGD","LU1032955483.USD","LU2471134879.HKD","IE0002141913.USD","IE00B2B36J28.USD","IE00BLSP4239.USD","LU2430703178.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4504","LU2505996509.AUD","IE00B3PB1722.GBP","LU2089984988.USD","LEGN","LU0640476718.USD","BK4568","LU2505996681.GBP","IE00BSNM7G36.USD","LU1894683348.USD","LU2471134952.CNY","BK4550","LU0345770308.USD","BK4139","JNJ","LU0070217475.USD","IE0034235303.USD","LU2430703251.USD","LU0234570918.USD","LU1244550577.SGD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","BK4581","IE00BFTCPJ56.SGD","BK4585","LU1718418525.SGD","LU0912757837.SGD","IE000M9KFDE8.USD","LU2133065610.SGD","LU1732799900.SGD","LU1280957306.USD"],"gpt_icon":0},{"id":"2590739329","title":"Cancer Study Buoys These Small Biotechs -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2590739329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590739329?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:31","pubTimestamp":1765312260,"startTime":"0","endTime":"0","summary":"The effectiveness of a leukemia drug from Terns Pharmaceuticals exceeded the hopes of many doctors and investors when the biotech firm reported early phase trial results this week.Terns shares jumped as much as 50% on the news that cancer cell counts fell over 99% in nearly three-fourths of the 38 leukemia patients treated for six months with the firm's once-daily pill. That's nearly twice the effectiveness of Scemblix, a similar drug from Novartis that has reached annual sales of a billion dollars.Arcellx was another stock lifted by study results reported at the American Society of Hematology meeting in Orlando, Fla. The shares popped 13% as a pivotal trial of its multiple-myeloma cell therapy showed fewer side effects with comparable efficacy to an established therapy from Legend Biotech. Shares of Legend slipped more than 10%.In about a hundred patients whose cancers advanced despite three or more other treatments, the Arcellx CAR-T eliminated measurable cancers in about three-quart","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU1074936037.SGD","LU0203345920.USD","LU1935042991.SGD","CAR","LU1929549753.HKD","LU2505996509.AUD","IE00B19Z3581.USD","BK4588","SG9999002224.SGD","IE00B19Z3B42.SGD","LU2089984988.USD","JNJ","LU2471134523.USD","LU2430703251.USD","BK4581","LU0640476718.USD","LU1032466523.USD","BK4578","LU1066051225.USD","LEGN","LU1496350502.SGD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","IE00BVYPNW00.USD","NVS","IE00B3T34201.USD","LU1066051498.USD","LU2129689605.HKD","LU1914381329.SGD","BK4532","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00B2B36J28.USD","LU0985320562.USD","BK4568","IE0002270589.USD","LU0058720904.USD","LU0889566641.SGD","IE00BFXG1179.USD","LU1261432733.SGD","LU2471134796.USD","LU2750360641.GBP","LU0345770993.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","BK4585","ACLX","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"1112969446","title":"HK Stock Movement | GENSCRIPT BIO (01548) Extends Losses by Over 11% in Afternoon Session as Affiliate Legend Biotech Drops 7% Overnight","url":"https://stock-news.laohu8.com/highlight/detail?id=1112969446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112969446?lang=en_us&edition=fundamental","pubTime":"2025-12-09 14:04","pubTimestamp":1765260257,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) saw its afternoon losses widen by more than 11%, falling 11.07% to HK$13.41 by the time of writing, with a turnover of HK$307 million. The decline follows an overnight drop of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","BK4585","HK0000306685.HKD","BK1576","HK0000306701.USD","BK4505","HK0000320223.HKD","BK1141","BK4588","BK4139","01548","BK1583","LEGN"],"gpt_icon":0},{"id":"2589354526","title":"Legend Biotech Is Maintained at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2589354526","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589354526?lang=en_us&edition=fundamental","pubTime":"2025-12-08 23:28","pubTimestamp":1765207680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 10:28 ET (15:28 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2589355359","title":"UBS Adjusts Legend Biotech Price Target to $48 From $54, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2589355359","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589355359?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:25","pubTimestamp":1765200333,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of Buy and mean price target of $71.87, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN"],"gpt_icon":0},{"id":"2589330034","title":"Legend Biotech Reports CARVYKTI® Delivers Median PFS of 50.4 Months in Multiple Myeloma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589330034","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589330034?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:30","pubTimestamp":1765197047,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8NvW69:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","HK0000306701.USD","01548","BK1576","BK4139","HK0000320264.USD","HK0000320223.HKD","BK4505","BK4588","BK1141","BK4585","BK1583","HK0000306685.HKD"],"gpt_icon":0},{"id":"2589874315","title":"GenScript Affiliate Legend Biotech Showcases CAR-T Data at 2025 ASH Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589874315","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589874315?lang=en_us&edition=fundamental","pubTime":"2025-12-07 18:45","pubTimestamp":1765104329,"startTime":"0","endTime":"0","summary":"GenScript Biotech Affiliate Legend Biotech Presents New CAR-T Data at 2025 ASH Annual Meeting. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nNDL9T3z3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","BK4505","BK4139","HK0000306685.HKD","HK0000306701.USD","LEGN","BK4588","BK4585","01548","BK1576","BK1141","BK1583","HK0000320223.HKD"],"gpt_icon":0},{"id":"2589821798","title":"BRIEF-Legend Biotech Highlights New Carvykti® Data In Multiple Myeloma And First-In-Human Results From Novel Car-T Platform In Non-Hodgkin Lymphoma At Ash 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589821798","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589821798?lang=en_us&edition=fundamental","pubTime":"2025-12-07 03:02","pubTimestamp":1765047729,"startTime":"0","endTime":"0","summary":"BRIEF-Legend Biotech Highlights New Carvykti Data In Multiple Myeloma And First-In-Human Results From Novel Car-T Platform In Non-Hodgkin Lymphoma At Ash 2025Dec 6 (Reuters) - Legend Biotech Corp LEGN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nFWN3XC0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","BK4505","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2589217688","title":"Legend Biotech Highlights New Carvykti® Data in Multiple Myeloma and First-in-Human Results From Novel CAR-T Platform in Non-Hodgkin Lymphoma at Ash 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589217688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589217688?lang=en_us&edition=fundamental","pubTime":"2025-12-07 03:00","pubTimestamp":1765047656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nFWN3XC0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4505","LEGN","BK4139"],"gpt_icon":0},{"id":"2589765821","title":"Legend Biotech Reports CARVYKTI Achieves 50.4-Month Median PFS in Multiple Myeloma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589765821","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589765821?lang=en_us&edition=fundamental","pubTime":"2025-12-07 03:00","pubTimestamp":1765047628,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation has announced new long-term clinical and translational data for its CARVYKTI  therapy from the CARTITUDE-1 and CARTITUDE-4 studies in patients with relapsed or refractory multiple myeloma. In triple-class-exposed patients who had received three prior lines of therapy, a median progression-free survival of 50.4 months was observed following a single infusion of CARVYKTI. Additionally, 80% of patients with standard-risk cytogenetics in the CARTITUDE-4 study remained progression-free and off treatment at 30 months after a single infusion. The results were presented at the American Society of Hematology  2025 annual meeting. Legend Biotech also presented first-in-human clinical data for its allogeneic CAR-T candidate LUCAR-G39D in adults with relapsed or refractory B-cell non-Hodgkin lymphoma. The study demonstrated a manageable safety profile and encouraging antitumor activity, with an overall response rate of 75% and a complete response rate of 37.5% among trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDL4lzfb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK1141","LU2210149790.SGD","HK0000320223.HKD","BK1583","BK4139","01548","IE00BGHQF748.EUR","NDAQ","LEGN","HK0000306701.USD","BK4588","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014013.SGD","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK1576","HK0000320264.USD","LU2210150020.SGD","HK0000306685.HKD","BK4505","BK4112"],"gpt_icon":0},{"id":"2586223171","title":"Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2586223171","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586223171?lang=en_us&edition=fundamental","pubTime":"2025-11-27 22:00","pubTimestamp":1764252000,"startTime":"0","endTime":"0","summary":"Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub SOMERSET, N.J. and  GHENT,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/27/3195718/0/en/Legend-Biotech-Awarded-2025-FIBA-Foreign-Investor-of-the-Year-by-Flanders-Investment-Trade.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","BK4585","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"1103943677","title":"Final Victory in Court! Former Legend Biotech Executive: A Triumph for Justice","url":"https://stock-news.laohu8.com/highlight/detail?id=1103943677","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103943677?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:02","pubTimestamp":1763643741,"startTime":"0","endTime":"0","summary":"In November 2025, the Supreme People's Court of China issued a final ruling on the \"Genscript Biotech vs. Fan Xiaohu Trade Secret Infringement Dispute,\" overturning the first-instance judgment by the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","LEGN","BK4585","BK4139"],"gpt_icon":0},{"id":"2583369658","title":"Why Genscript Biotech (SEHK:1548) Is Up 8.0% After Legend Biotech’s CARVYKTI Drives Smaller Q3 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2583369658","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583369658?lang=en_us&edition=fundamental","pubTime":"2025-11-15 17:32","pubTimestamp":1763199121,"startTime":"0","endTime":"0","summary":"Earlier this week, Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, reported a significant reduction in net losses for the third quarter of 2025, alongside strong sales growth for its CARVYKTI product.\nThis disclosure, released around Genscript’s Analyst/Investor Day, places enhanced focus on the financial ties between the two companies and the implications for Genscript’s broader business outlook.\nWe’ll now explore how Legend Biotech’s improved...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/why-genscript-biotech-sehk1548-is-up-80-after-legend-biotech","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/why-genscript-biotech-sehk1548-is-up-80-after-legend-biotech","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000320223.HKD","HK0000306701.USD","BK4505","HK0000306685.HKD","BK1576","BK4139","BK1141","BK4585","LEGN","BK1583","HK0000320264.USD","BK4588","01548"],"gpt_icon":0},{"id":"2583590378","title":"Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia","url":"https://stock-news.laohu8.com/highlight/detail?id=2583590378","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583590378?lang=en_us&edition=fundamental","pubTime":"2025-11-14 01:08","pubTimestamp":1763053680,"startTime":"0","endTime":"0","summary":"31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation The facility will support CAR-T R&D in potential oncology and imm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187686/0/en/Legend-Biotech-Celebrates-Official-Opening-of-New-State-of-the-Art-Cell-Therapy-Research-and-Development-Facility-in-Philadelphia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STT","BK4505","LU1883839398.USD","IE00B64PRP62.GBP","LU1894683264.USD","LEGN","LU1894683348.USD","BK4135","IE0034235188.USD","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","BK4585","LU0061475181.USD","BK4139"],"gpt_icon":0},{"id":"2583592362","title":"Morgan Stanley Reaffirms Their Buy Rating on Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583592362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583592362?lang=en_us&edition=fundamental","pubTime":"2025-11-13 23:55","pubTimestamp":1763049340,"startTime":"0","endTime":"0","summary":"In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Legend Biotech, with a price target of $83.00. According t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-legend-biotech-legn-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-legend-biotech-legn-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN"],"gpt_icon":0},{"id":"2583966505","title":"Legend Biotech Is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2583966505","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583966505?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:19","pubTimestamp":1763043540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2025 09:19 ET (14:19 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2583359360","title":"Cantor Fitzgerald Sticks to Their Buy Rating for Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583359360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583359360?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:36","pubTimestamp":1763040991,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Derek Soderberg reiterated a Buy rating on Legend Biotech today and set a price target of $75.00. According to TipRanks, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-their-buy-rating-for-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-their-buy-rating-for-legend-biotech-legn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN"],"gpt_icon":0},{"id":"2583056019","title":"Legend Biotech : Barclays Cuts Target Price to $90 From $94","url":"https://stock-news.laohu8.com/highlight/detail?id=2583056019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583056019?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:57","pubTimestamp":1763038654,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nAZN4QR1ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","BK4585","LEGN","BK4588"],"gpt_icon":0},{"id":"2583567847","title":"Truist Lowers Price Target on Legend Biotech to $70 From $71, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2583567847","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583567847?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:21","pubTimestamp":1763036488,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of buy and mean price target of $74.62, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN"],"gpt_icon":0},{"id":"2583562999","title":"Legend Biotech Corp : Truist Securities Cuts Target Price to $70 From $71","url":"https://stock-news.laohu8.com/highlight/detail?id=2583562999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583562999?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:09","pubTimestamp":1763035767,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4505","LEGN","BK4588","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":-0.1582},{"period":"1month","weight":-0.2605},{"period":"3month","weight":-0.3095},{"period":"6month","weight":-0.3657},{"period":"1year","weight":-0.3836},{"period":"ytd","weight":-0.2821}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.018049},{"month":2,"riseRate":0.4,"avgChangeRate":0.004169},{"month":3,"riseRate":0.4,"avgChangeRate":-0.028053},{"month":4,"riseRate":0.8,"avgChangeRate":0.075373},{"month":5,"riseRate":0.4,"avgChangeRate":0.007649},{"month":6,"riseRate":1,"avgChangeRate":0.150366},{"month":7,"riseRate":0.666667,"avgChangeRate":0.033873},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.05555},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.023313},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.000245},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.020911},{"month":12,"riseRate":0,"avgChangeRate":-0.0955}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction